Home › Tracheal Stenosis › NCT07258784
RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis
Who can join
Ages 18 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * Patients with benign tracheal stenosis Exclusion Criteria: * Malignancy. active infection
About the study
Benign tracheal stenosis is a rare but potentially life-threatening condition, typically resulting from fibroinflammatory scarring. It can be secondary to iatrogenic etiologies such as intubation or tracheostomy , as well as autoimmune diseases and being idiopathic. Patients typically undergoes endoscopic or surgical interventions to open up the airways. This project will analyze resected or biopsied tissue from patients with benign tracheal stenosis to define disease-specific RNA expression profiles.
What is being tested
- Biopsy or surgery (procedure)
Sponsor: University of Maryland, Baltimore · Participants: 10 · Started: Sep 11, 2025
Contact the study team
- Chenchen Zhang, MD · Phone: 14103288141
Official record on ClinicalTrials.gov — NCT07258784
Locations in the U.S.
| Maryland | University of Maryland, Baltimore |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.